63496 Federal Register / Vol. 75, No. 199 / Friday, October 15, 2010 / Notices 

Transportation, Warehousing, and 

Utilities Sector Councils. Updates will 

also be given on the Mid-Decade Review 

of NORA and the NORA Symposium 

2011. After each update, there will be 

time to discuss partnership 

opportunities. 

Status: The meeting is open to the 

public, limited only by the capacities of 

the conference call and conference room 

facilities. There is limited space 

available in the meeting room (capacity 

34). Therefore, information to allow 

participation in the meeting through the 

Internet (to see the slides) and a 

teleconference call (capacity 50) will be 

provided to registered participants. 

Participants are encouraged to consider 

attending by this method. Each 

participant is requested to register for 

the free meeting by sending an e-mail to 

noracoordinator@cdc.gov containing the 

participant’s name, organization name, 

contact telephone number on the day of 

the meeting, and preference for 

participation by Web meeting 

(requirements include: computer, 

Internet connection, and telephone, 

preferably with ‘mute’ capability) or in 

person. An e-mail confirming 

registration will include the details 

needed to participate in the Web 

meeting. Non-US citizens are 

encouraged to participate in the Web 

meeting. Non-US citizens who do not 

register to attend in person on or before 

January 7, 2011, will not be granted 

access to the meeting site and will not 

be able to attend the meeting in-person 

due to mandatory security clearance 

procedures at the Patriots Plaza facility. 

Background: NORA is a partnership 

program to stimulate innovative 

research in occupational safety and 

health leading to improved workplace 

practices. Unveiled in 1996, NORA has 

become a research framework for the 

nation. Diverse parties collaborate to 

identify the most critical issues in 

workplace safety and health. Partners 

then work together to develop goals and 

objectives for addressing those needs 

and to move the research results into 

practice. The NIOSH role is facilitator of 

the process. For more information about 

NORA, see http://www.cdc.gov/niosh/ 

nora/about.html. 

Since 2006, NORA has been 

structured according to industrial 

sectors. Ten major sector groups have 

been defined using the North American 

Industrial Classification System 

(NAICS). After receiving public input 

through the Web and town hall 

meetings, ten NORA Sector Councils 

have been working to define sectorspecific strategic plans for conducting 

research and moving the results into 

widespread practice. During 2008–10, 

most of these Councils posted draft 

strategic plans for public comment and 

eight have posted finalized National 

Sector Agendas after considering 

comments on the drafts. For the 

National Sector Agendas, see http:// 

www.cdc.gov/niosh/nora/. 

FOR FURTHER INFORMATION CONTACT: 

Sidney C. Soderholm, Ph.D, NORA 

Coordinator, E-mail 

noracoordinator@cdc.gov, telephone 

(202) 245–0665. 

Dated: October 8, 2010. 

Tanja Popovic, 

Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2010–25973 Filed 10–14–10; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Arthritis and 

Musculoskeletal and Skin Diseases Special 

Grants Review Committee. 

Date: October 25–26, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Helen Lin, PhD, Scientific 

Review Officer, NIH/NIAMS/RB, 6701 

Democracy Blvd., Suite 800, Plaza One, 

Bethesda, MD 20817, 301–594–4952, 

linh1@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: October 8, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–26068 Filed 10–14–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Council for the Elimination of 

Tuberculosis (ACET) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 

8:30 a.m.–5:30 p.m., November 2, 2010. 

8:30 a.m.–2:30 p.m., November 3, 2010. 

Place: Corporate Square, Building 8, 1st 

Floor Conference Room, Atlanta, Georgia 

30333, telephone (404) 639–8317. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 100 people. 

Purpose: This council advises and makes 

recommendations to the Secretary of Health 

and Human Services, the Assistant Secretary 

for Health, and the Director, CDC, regarding 

the elimination of tuberculosis. Specifically, 

the Council makes recommendations 

regarding policies, strategies, objectives, and 

priorities; addresses the development and 

application of new technologies; and reviews 

the extent to which progress has been made 

toward eliminating tuberculosis. 

Matters To Be Discussed: Agenda items 

include issues pertaining to TB outbreaks 

within the homeless population; TB issues 

along the U.S.-Mexico border; foreign born 

guidelines update and endorsement; Bacille 

Calmette-Gue ́rin (BCG) guidelines update 

and endorsement; STOP TB USA retreat 

update; and other related tuberculosis issues. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Margie Scott-Cseh, CDC, 1600 Clifton Road, 

NE., Mailstop E–07, Atlanta, Georgia 30333, 

telephone (404) 639–8317. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: October 6, 2010. 

Elaine Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–25915 Filed 10–14–10; 8:45 am] 

BILLING CODE 4163–18–P 

mstockstill on DSKH9S0YB1PROD with NOTICES